Beam Therapeutics Inc. (BEAM) vs Clover Health Investments, Corp. (CLOV)

A side-by-side comparison of Beam Therapeutics Inc. and Clover Health Investments, Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BEAM vs CLOV

growth of $100 · dividends reinvested · last 6y
BEAM +2.9% (+0.5%/yr)CLOV -53.6% (-12.0%/yr)BEAM compounded faster over this window
0100200300400500Start $100202120222023202420252026$103$46
BEAM CLOV

BEAM vs CLOV: by the numbers

  • •BEAM is the larger company ($2.66B vs $2.40B market cap).
  • •Both run net losses; CLOV's is the smaller (-0.74% vs -54.75% net margin).
  • •BEAM grew revenue faster over the past five years (479.04% vs 21.18% CAGR).

Metrics side by side

Valuation

MetricBEAMCLOV
Forward P/EN/A82.53
P/S ratio17.040.97
P/B ratio2.496.37
FCF yieldN/A3.10%

Profitability

MetricBEAMCLOV
Gross margin84.05%18.57%
Operating margin-274.57%-0.74%
Net margin-54.75%-0.74%
ROE-8.00%-4.88%
ROIC-28.96%-4.62%

Growth (annualized)

MetricBEAMCLOV
Revenue CAGR (5Y)479.04%21.18%
Total return CAGR (5Y)-21.41%-8.36%

Frequently asked

Which has grown faster, BEAM or CLOV?
Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus CLOV at 21.18%.
How have BEAM and CLOV total returns compared?
Over the past 5 years, BEAM delivered -21.41% and CLOV delivered -8.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.